Drugmaker Lilly said its experimental pill, orforglipron, produced better blood sugar and weight loss for diabetes patients results in a new head-to-head clinical trial.

Milk used to make the cottage cheese may not have been fully pasteurized, which means the product could harbor harmful bacteria.